We create groundbreaking technology that is friendly, caring and more human
Who we are
Empatica, an MIT spin-off, is a pioneer in offering continuous, passive, and unobtrusive monitoring for patients with neurological conditions.
We build software and algorithms to advance understanding of human behavior through wearable sensors. Our technology empowers thousands of patients, clinicians, and researchers with real-time human insight, driven by physiological and behavioral biomarkers.
We work with the best institutions in the world
3000+ institutional clients from 40+ countries
A world class team in AI and Medicine
Rosalind Picard, ScD
Chief Scientist
Founder and Director of the Affective Computing Group at the MIT Media Lab and Faculty Chair, MIT Mind+Hand+Heart Wellbeing Initiative. Dedicated to improving future health.
Matteo Lai
Chief Executive Officer
Trained as an architect and engineer with a Double MSc in Architecture and a Master in Innovation Management.
Simone Tognetti, PhD
Chief Technology Officer
PhD in Artificial Intelligence and Computer Science, passionate about making things work.
Maurizio Garbarino, PhD
Chief Software Architect
PhD in Computer Science, focused in Affective Computing research. Driven by enabling the advancement of research via innovative software and hardware solutions.
Marisa Cruz, MD
Chief Medical Officer
MD from Johns Hopkins, double board certified in Internal Medicine and Endocrinology, former FDA Senior Medical Advisor, passionate about using technology to improve patient outcomes.
Ivan Cenci
General Manager
Double MSc in Biomedical Engineering, a healthcare enthusiast driven by delivering results.
100+ passionate Empaticans across 3 continents
We are a harmonious ecosystem of experts innovating across a range of fields. We are driven by empathy and connected by our shared passion to revolutionize healthcare through innovative technology, in order to provide better outcomes for millions of patients across the world. Our holistic approach and interdisciplinary skills allow us to build beautiful products that seamlessly integrate hardware, software, design and data science.
We are hiring!
Supported by some of the leading figures in medical research and technology
Orrin Devinsky
MD, PhD. Director NYU Comprehensive Epilepsy Center
Santiago Arroyo
Chief Medical Officer at Momenta Pharmaceuticals
Matt Goodwin
PhD. Northeastern University. Co-Chair Autism Speaks
Adam Gazzaley
MD, PhD. Executive Director, Neurospace at UCSF
Robert Stickgold
PhD. Director, Center for Sleep and Cognition, Harvard Medical School
Matt Nock
Edgar Pierce Professor of Psychology, Harvard College Professor
Press releases
Empatica partnering with U.S. Army MRDC to deploy COVID-19 early detection wearable November 06, 2020
Empatica and BARDA Join Forces to Validate Wearable System That Detects COVID-19 Before Symptoms Appear June 19, 2020
Empatica Announces EmbracePlus: NASA Medical Quality in a Down-to-Earth Smart Watch November 19, 2019
Eisai and Empatica Agreement to Co-promote Embrace2 device for people living with epilepsy in the U.S. February 19, 2019
Contacts & Offices
Boston, USA
Milan, Italy
Seoul, Republic of Korea
Empatica Media Kits
We honor a 1-year warranty
30-day Money Back Guaranteed
Includes a 30 days Plus Plan Free Trial
| Subtotal |
Shipping  | USD |
| Estimated Total |
Select your Location
Embrace is currently available only in English. Embrace is an investigational device in the USA and a medical device in the EU. If you do not see your country listed, please visit the International site.
Please note that Embrace Alert System is not available in the following countries .